APA (7th ed.) Citation

Ravandi, F., Jorgensen, J. L., Thomas, D. A., O'Brien, S., Garris, R., Faderl, S., . . . Kantarjian, H. M. (2013). Detection of MRD may predict the outcome of patients with Philadelphia chromosome–positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood, 122(7), 1214-1221. https://doi.org/10.1182/blood-2012-11-466482

Chicago Style (17th ed.) Citation

Ravandi, Farhad, et al. "Detection of MRD May Predict the Outcome of Patients with Philadelphia Chromosome–positive ALL Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy." Blood 122, no. 7 (2013): 1214-1221. https://doi.org/10.1182/blood-2012-11-466482.

MLA (9th ed.) Citation

Ravandi, Farhad, et al. "Detection of MRD May Predict the Outcome of Patients with Philadelphia Chromosome–positive ALL Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy." Blood, vol. 122, no. 7, 2013, pp. 1214-1221, https://doi.org/10.1182/blood-2012-11-466482.